Cell penetrating peptides can exert biological activity: A review

Biomolecular Concepts

Volumn 1, Issue 2, 2010, Pages 109-116

  Brugnano, Jamie ^a   Ward, Brian C ^a,b   Panitch, Alyssa ^a  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biological activity; cell penetrating peptides; gene expression; protein kinase; protein transduction domains; proteolytic activity

Indexed keywords

EID: 80053586988     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc.2010.016     Document Type: Review

References (74)

1. Kameyama S, Horie M, Kikuchi T, Omura T, Takeuchi T, Nakase I, Sugiura Y, Futaki, S. Effects of cell-permeating peptide binding on the distribution of 125I-labeled Fab fragment in rats. Bioconjug Chem 2006; 17: 597-602
2. Kameyama S, Okada R, Kikuchi T, Omura T, Nakase I, Takeuchi T, Sugiura Y, Futaki S. Distribution of immunoglobulin Fab fragment conjugated with HIV-1 REV peptide following intravenous administration in rats. Mol Pharm 2006; 3: 174-80
3. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999; 10: 186-91
4. Abes R, Arzumanov AA, Moulton HM, Abes S, Ivanova GD, Iversen PL, Gait MJ, Lebleu B. Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc T 2007; 35: 775-9
5. Eguchi A, Dowdy SF. siRNA delivery using peptide transduction domains. Trends Pharmacol Sci 2009; 30: 341-5
6. Eto Y, Yoshioka Y, Asavatanabodee R, Kida S, Maeda M, Mukai Y, Mizuguchi H, Kawasaki K, Okada N, Nakagawa S. Transduction of adenovirus vectors modified with cell-penetrating peptides. Peptides 2009; 30: 1548-52
7. Sawant R, Torchilin V. Intracellular transduction using cell-penetrating peptides. Mol Biosyst 2010; 6: 628-40
8. Dietz GP, Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 2004; 27: 85-131
9. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-Activator protein. Cell 1988; 55: 1179-88
10. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55: 1189-93
11. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997; 272: 16010-7
12. Perez F, Joliot A, Bloch-Gallego E, Zahraoui A, Triller A, Prochiantz A. Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J Cell Sci 1992; 102: 717-22
13. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999; 285: 1569-72
14. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. Cell-penetrating peptides-A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585-90
15. Gump JM, June RK, Dowdy SF. Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction. J Biol Chem 2010; 285: 1500-7
16. Bertrand JR, Malvy C, Auguste T, Tóth GK, Kiss-Iv#x000E1;nkovits O, Illyés E, Hollósi M, Bottka S, Laczkó I. Synthesis and studies on cell-penetrating peptides. Bioconjug Chem 2009; 20: 1307-14
17. Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, Langel U, EL Andaloussi S. Distinct uptake routes of cell penetrating peptide conjugates. Bioconjug Chem 2008; 19: 2535-42
18. Jiao CY, Delaroche D, Burlina F, Alves ID, Chassaing G, Sagan S. Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem 2009; 284: 33957-65
19. Vives E. Cellular uptake wcorrection of utakex of the Tat peptide: an endocytosis mechanism following ionic interactions. J Mol Recognit 2003; 16: 265-71
20. Arnt CR, Chiorean MV, Heldebrant MP, Gores GJ, Kaufmann SH. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol Chem 2002; 277: 44236-43
21. Kashiwagi H, McDunn JE, Goedegebuure PS, Gaffney MC, Chang K, Trinkaus K, Piwnica-Worms D, Hotchkiss RS, Hawkins WG. TAT-Bim induces extensive apoptosis in cancer cells. Ann Surg Oncol 2007; 14: 1763-71
22. Watkins CL, Brennan P, Fegan C, Takayama K, Nakase I, Futaki S, Jones AT. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. J Control Release 2009; 140: 237-44
23. Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F, Salmona M, Colella G, Bruno S, Mancuso T, Bagnasco L, Russo P, Parodi S. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-Type peptide fused to an internalization sequence. Cancer Res 1998; 58: 3654-9
24. Mutoh M, Lung FD, Long YQ, Roller PP, Sikorski RS, O'Connor PM. A p21(Waf1/Cip1)carboxyl-Terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. Cancer Res 1999; 59: 3480-8
25. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994; 91: 664-8
26. Niesner U, Halin C, Lozzi L, Günthert M, Neri P, Wunderli-Allenspach H, Zardi L, Neri D. Quantitation of the tumortargeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides. Bioconjug Chem 2002; 13: 729-36
27. Duchardt F, Ruttekolk IR, Verdurmen WP, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DW, Vuister GW, Ulrich A, de Waard M, Brock R. A cellpenetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J Biol Chem 2009; 284: 36099-108
28. Kamide K, Nakakubo H, Uno S, Fukamizu A. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications. Int J Mol Med 2010; 25: 41-51
29. Rhee M, Davis P. Mechanism of uptake of C105Y, a novel cellpenetrating peptide. J Biol Chem 2006; 281: 1233-40
30. Gao C, Mao S, Ditzel HJ, Farnaes L, Wirsching P, Lerner RA, Janda KD. A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. Bioorg Med Chem 2002; 10: 4057-65
31. Ward B, Seal BL, Brophy CM, Panitch A. Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce. J Pept Sci 2009; 15: 668-74
32. Pooga M, Hallbrink M, Zorko M, Langel U. Cell penetration by transportan. FASEB J 1998; 12: 67-77
33. Chen Y, Shen Y, Guo X, Zhang C, Yang W, Ma M, Liu S, Zhang M, Wen LP. Transdermal protein delivery by a coad ministered peptide identified via phage display. Nat Biotechnol 2006; 24: 455-60
34. Rousselle C, Clair P, Lefauconnier JM, Kaczorek M, Scherrmann JM, Temsamani J. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vectormediated strategy. Mol Pharmacol 2000; 57: 679-86
35. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001; 19: 1173-6
36. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001; 276: 5836-40
37. Soomets U, Lindgren M, Gallet X, Hällbrink M, Elmquist A, Balaspiri L, Zorko M, Pooga M, Brasseur R, Langel U. Deletion analogues of transportan. Biochim Biophys Acta 2000; 1467: 165-76
38. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994; 269: 10444-50
39. Crombez L, Aldrian-Herrada G, Konate K, Nguyen QN, McMaster GK, Brasseur R, Heitz F, Divita G. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther 2009; 17: 95-103
40. Elmquist A, Lindgren M, Bartfai T, Langel U. VE-cadherinderived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 2001; 269: 237-44
41. Saphire AC, Guan T, Schirmer EC, Nemerow GR, Gerace L. Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J Biol Chem 2000; 275: 4298-304
42. Lopes LB, Flynn C, Komalavilas P, Panitch A, Brophy CM, Seal BL. Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor. Biochem Biophys Res Commun 2009; 382: 535-9
43. Elliott G, O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997; 88: 223-33
44. Zhang L, Torgerson TR, Liu XY, Timmons S, Colosia AD, Hawiger J, Tam JP. Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. Proc Natl Acad Sci USA 1998; 95: 9184-9
45. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270: 14255-8
46. Oehlke J, Krause E, Wiesner B, Beyermann M, Bienert M. Nonendocytic, amphipathicity dependent cellular uptake of helical model peptides. Protein Peptide Lett 1996; 3: 393-8
47. Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 2001; 61: 474-7
48. Shen WC, Ryser HJ. Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. Proc Natl Acad Sci USA 1978; 75: 1872-6
49. Lang S, Rothen-Rutishauser B, Perriard JC, Schmidt MC, Merkle HP. Permeation and pathways of human calcitonin (hCT) across excised bovine nasal mucosa. Peptides 1998; 19: 599-607
50. Schmidt MC, Rothen-Rutishauser B, Rist B, Beck-Sickinger A, Wunderli-Allenspach H, Rubas W, Sadée W, Merkle HP. Translocation of human calcitonin in respiratory nasal epithelium is associated with self-Assembly in lipid membrane. Biochemistry 1998; 37: 16582-90
51. Rennert R, Wespe C, Beck-Sickinger AG, Neundorf I. Developing novel hCT derived cell-penetrating peptides with improved metabolic stability. Biochim Biophys Acta 2006; 1758: 347-54
52. Oehlke J, Krause E, Wiesner B, Beyermann M, Bienert M. Extensive cellular uptake into endothelial cells of an amphipathic beta-sheet forming peptide. FEBS Lett 1997; 415: 196-9
53. Bong DT, Steinem C, Janshoff A, Johnson JE, Reza Ghadiri M. A highly membrane-Active peptide in Flock House virus: implications for the mechanism of nodavirus infection. Chem Biol 1999; 6: 473-81
54. Sadler K, Eom KD, Yang JL, Dimitrova Y, Tam JP. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 2002; 41: 14150-7
55. De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochem J 2005; 390: 407-18
56. Morris MC, Vidal P, Chaloin L, Heitz F, Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 1997; 25: 2730-6
57. El-Andaloussi S, Johansson HJ, Holm T, Langel U. A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol Ther 2007; 15: 1820-6
58. Lundberg P, El-Andaloussi S, Sutlu T, Johansson H, Langel U. Delivery of short interfering RNA using endosomolytic cellpenetrating peptides. FASEB J 2007; 21: 2664-71
59. Mano M, Teodosio C, Paiva A, Simoes S, de Lima MCP. On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem J 2005; 390: 603-12
60. Fernandez-Carneado J, Kogan MJ, Castel S, Giralt E. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-Terminal domain of gamma-zein. Angew Chem Int Ed Engl 2004; 43: 1811-4
61. Mueller J, Kretzschmar I, Volkmer R, Boisguerin P. Comparison of cellular uptake using 22 CPPs in 4 different cell lines. Bioconjug Chem 2008; 19: 2363-74
62. Cameron A, Appel J, Houghten RA, Lindberg I. Polyarginines are potent furin inhibitors. J Biol Chem 2000; 275: 36741-9
63. Horn M, Pavlik M, Doleckova L, Baudys M, Mares M. Arginine-based structures are specific inhibitors of cathepsin C. Application of peptide combinatorial libraries. Eur J Biochem 2000; 267: 3330-6
64. Fugere M, Appel J, Houghten RA, Lindberg I, Day R. Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences. Mol Pharmacol 2007; 71: 323-32
65. Kloss A, Henklein P, Siele D, Schmolke M, Apcher S, Kuehn L, Sheppard PW, Dahlmann B. The cell-penetrating peptide octa-Arginine is a potent inhibitor of proteasome activities. Eur J Pharm Biopharm 2009; 72: 219-25
66. Kilk K, Mahlapuu R, Soomets U, Langel U. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling. Toxicology 2009; 265: 87-95
67. Kuo JH, Jan MS, Lin YL, Lin C. Interactions between octaarginine and U-937 human macrophages: global gene expression profiling, superoxide anion content, and cytokine production. J Control Release 2009; 139: 197-204
68. Delaroche D, Cantrelle FX, Subra F, Van Heijenoort C, Guittet E, Jiao CY, Blanchoin L, Chassaing G, Lavielle S, Auclair C, Sagan S. Cell-penetrating peptides with intracellular actinremodeling activity in malignant fibroblasts. J Biol Chem 2010; 285: 7712-21
69. Moschos SA, Jones SW, Perry MM, Williams AE, Erjefalt JS, Turner JJ, Barnes PJ, Sproat BS, Gait MJ, Lindsay MA. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem 2007; 18: 1450-9
70. Waldeck W, Pipkorn R, Korn B, Mueller G, Schick M, Tóth K, Wiessler M, Didinger B, Braun K. Transporter molecules influence the gene expression in HeLa cells. Int J Med Sci 2009; 6: 18-27
71. Fotin-Mleczek M, Welte S, Mader O, Duchardt F, Fischer R, Hufnagel H, Scheurich P, Brock R. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J Cell Sci 2005; 118: 3339-51
72. Hayess K, Benndorf R. Effect of protein kinase inhibitors on activity of mammalian small heat-shock protein (HSP25) kinase. Biochem Pharmacol 1997; 53: 1239-47
73. Yamada T, Mehta RR, Lekmine F, Christov K, King ML, Majumdar D, Shilkaitis A, Green A, Bratescu L, Beattie CW, Das Gupta TK. A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Mol Cancer Ther 2009; 8: 2947-58
74. Dreiza CM, Brophy CM, Komalavilas P, Furnish EJ, Joshi L, Pallero MA, Murphy-Ullrich JE, von Rechenberg M, Ho YS, Richardson B, Xu N, Zhen Y, Peltier JM, Panitch A. Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics. FASEB J 2005; 19: 261-3